Minerva Announces Leadership Transition
Minerva Neurosciences, a clinical-stage biotech focused on CNS disorders, announced that Jim O'Connor will become Chief Business Officer, replacing departing President Geoff Race who will remain as consultant. The leadership change occurs as Minerva prepares to advance its key drug candidate, roluperidone, through a planned Phase 3 trial targeting …